Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Formative Research

Date Submitted: Jun 16, 2026
Open Peer Review Period: Jun 17, 2026 - Aug 12, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

A Governed Evidence-Generation System for Health-AI Organizations: Development and Formative Evaluation

  • Katherine Monsalve; 
  • Jose Zea; 
  • Natalia Castano-Villegas; 
  • Laura Velásquez

ABSTRACT

Background:

large language models are increasingly used to support literature review, analysis, and manuscript drafting. In health-AI research, evidence generation requires more than generic writing assistance: citation verification, researcher review, protocol-based writing, and submission gates. Existing AI writing systems have not described how these requirements can be embedded into a health research team’s daily workflow.

Objective:

this paper describes Gabo, a governed evidence-generation system for health-AI organizations, with emphasis on workflow design, issue-based state management, citation-audit checkpoints, and researcher review gates.

Methods:

we conducted a retrospective methodological description of two manuscript-production cases. The unit of analysis was the writing workflow rather than model performance. Case 1 describes a medical billing audit manuscript; Case 2 describes a clinical Automated Machine Learning (AutoML) methodology manuscript.

Results:

the system operated through six layers. Case 1 produced 22 manuscript versions across 12 dedicated writing tasks, with iterative researcher corrections throughout each section. Case 2 reached submission through 12 manuscript versions, incorporating accumulated learning from Case 1, including a technical review by the engineering team at version 10. A structured self-review identified nine system gaps; eight were corrected within the same development cycle.

Conclusions:

Gabo is described as a potentially replicable specialized AI writing system for health research evidence generation. The observed writing progression across two cases supports the feasibility of a researcher-governed, task-managed approach to scientific writing in health organizations. A structured formative review identified nine governance gaps; eight were corrected within the same development cycle, supporting the view that the issue-based governance model supports not only writing production but iterative system improvement. The framework illustrates the scientific evidence-generation workflow applied to two manuscripts and documents the sequential execution of the system as a formative assessment of its operational feasibility. Future studies should prospectively evaluate the quality of produced manuscripts, as well as the transferability, scalability, and adoption of the system in broader research settings. Clinical Trial: N/A


 Citation

Please cite as:

Monsalve K, Zea J, Castano-Villegas N, Velásquez L

A Governed Evidence-Generation System for Health-AI Organizations: Development and Formative Evaluation

JMIR Preprints. 16/06/2026:104857

DOI: 10.2196/preprints.104857

URL: https://preprints.jmir.org/preprint/104857

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.